Manufacturers’ Drug Discount Obligation Won’t Be Reduced In Part D Retiree Plans Under CMS Policy

A new Medicare Part D policy on calculating the 50% discount on branded drugs in the coverage gap will not allow for reduced manufacturer payments when beneficiaries are enrolled in employer group waiver plans, despite arguments from drug firms.